HighVista Strategies’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-165,173
| Closed | -$778K | – | 154 |
|
2024
Q1 | $778K | Hold |
165,173
| – | – | 0.28% | 103 |
|
2023
Q4 | $1.21M | Hold |
165,173
| – | – | 0.44% | 77 |
|
2023
Q3 | $2M | Hold |
165,173
| – | – | 0.92% | 32 |
|
2023
Q2 | $1.75M | Buy |
165,173
+283
| +0.2% | +$2.99K | 0.8% | 36 |
|
2023
Q1 | $1.62M | Hold |
164,890
| – | – | 1.32% | 28 |
|
2022
Q4 | $2.43M | Sell |
164,890
-139,291
| -46% | -$2.05M | 1.44% | 22 |
|
2022
Q3 | $3.69M | Buy |
304,181
+151,581
| +99% | +$1.84M | 2.11% | 10 |
|
2022
Q2 | $2.14M | Buy |
152,600
+9,225
| +6% | +$129K | 1.29% | 24 |
|
2022
Q1 | $2.04M | Buy |
143,375
+99,878
| +230% | +$1.42M | 1.3% | 22 |
|
2021
Q4 | $917K | Buy |
43,497
+7,393
| +20% | +$156K | 0.73% | 52 |
|
2021
Q3 | $947K | Buy |
+36,104
| New | +$947K | 0.63% | 56 |
|